These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35938485)

  • 41. Patient satisfaction with pharmacist-led chronic care management services combined with medication synchronization.
    Awad M; Furdich K; Webb D
    Am J Health Syst Pharm; 2023 Sep; 80(19):1350-1356. PubMed ID: 37368435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pharmacist-managed cardiovascular risk-reduction clinic for individuals experiencing serious mental illness.
    Gonzalvo JD; Hamm JA; Shan M
    J Am Pharm Assoc (2003); 2019; 59(5):698-703. PubMed ID: 31324536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of a pharmacist-supervised outpatient diabetes treatment clinic.
    Collier IA; Baker DM
    Am J Health Syst Pharm; 2014 Jan; 71(1):27-36. PubMed ID: 24352179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of a Pharmacist-Led Group Diabetes Class.
    Lakey H; Boehmer K; Johnson C
    J Pharm Pract; 2022 Feb; 35(1):54-56. PubMed ID: 32783491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program.
    Theising KM; Fritschle TL; Scholfield AM; Hicks EL; Schymik ML
    Pharmacotherapy; 2015 Nov; 35(11):e159-63. PubMed ID: 26598100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes.
    Narain KDC; Moreno G; Bell DS; Chen L; Tseng CH; Follett RW; Skootsky S; Mangione CM
    JAMA Netw Open; 2023 Sep; 6(9):e2335409. PubMed ID: 37768663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Frontiers in Diabetes Care: Quality Improvement Study of a Population Health Team in Rural Critical Access Hospitals.
    Tanumihardjo JP; Kuther S; Wan W; Gunter KE; McGrath K; O'Neal Y; Wilkinson C; Zhu M; Packer C; Petersen V; Chin MH
    J Gen Intern Med; 2023 Mar; 38(Suppl 1):56-64. PubMed ID: 36864269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expansion of clinical pharmacist positions through sustainable funding.
    Moore GD; Kosirog ER; Vande Griend JP; Freund JE; Saseen JJ
    Am J Health Syst Pharm; 2018 Jul; 75(13):978-981. PubMed ID: 29941536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program.
    Fera T; Bluml BM; Ellis WM; Schaller CW; Garrett DG
    J Am Pharm Assoc (2003); 2008; 48(2):181-190. PubMed ID: 18359731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the change in glycated hemoglobin for patients in an employee health program formerly managed by a pharmacist-run ambulatory care clinic.
    Bou-Ghazale L; Oldham E; Bundeff AW; Hwang AY
    Am J Health Syst Pharm; 2023 Oct; 80(21):1564-1569. PubMed ID: 37486825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment.
    Ray S; Lokken J; Whyte C; Baumann A; Oldani M
    J Interprof Care; 2020; 34(1):27-35. PubMed ID: 31381470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service.
    Johnson CL; Nicholas A; Divine H; Perrier DG; Blumenschein K; Steinke DT
    J Am Pharm Assoc (2003); 2008; 48(6):722-30. PubMed ID: 19019800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacist impact on health outcomes in a homeless population.
    Bahrami S; Chang C; Alvarez KS; Lutek K; Nguyen S; Hegde A
    J Am Pharm Assoc (2003); 2020; 60(3):485-490. PubMed ID: 31901441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Participant engagement in a community health worker-delivered intervention and type 2 diabetes clinical outcomes: a quasiexperimental study in MexicanAmericans.
    Reininger BM; Lopez J; Zolezzi M; Lee M; Mitchell-Bennett LA; Xu T; Park SK; Saldana MV; Perez L; Payne LY; Collier C; McCormick JB
    BMJ Open; 2022 Nov; 12(11):e063521. PubMed ID: 36446462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
    Wallgren S; Berry-Cabán CS; Bowers L
    Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.